B6-hSERPINA1 Mouse
Product Name
B6-hSERPINA1 Mouse
Product ID
C001697
Strain Name
C57BL/6JCya-Serpina1a&Serpina1b&Serpina1c&Serpina1d&Serpina1etm2(hSERPINA1)/Cya
Backgroud
C57BL/6JCya
Status
When using this mouse strain in a publication, please cite “B6-hSERPINA1 Mouse (Catalog C001697) were purchased from Cyagen.”
Product Type
Age
Genotype
Sex
Quantity
Gene Name
SERPINA1
Gene Alias
PI, A1A, AAT, PI1, A1AT, nNIF, PRO2275, alpha1AT
NCBI ID
Chromosome
Chr 14 (Human)
MGI ID
--
Datasheet
Strain Description
The SERPINA1 gene encodes alpha-1 antitrypsin (AAT), a serine protease inhibitor primarily synthesized and secreted by hepatocytes in the liver, with additional expression in immune cells such as macrophages. AAT's main function is to inhibit neutrophil-derived proteases (e.g., elastase) to protect lung tissue from enzymatic degradation. This glycoprotein is crucial for maintaining lung tissue elasticity and regulating inflammatory responses. Mutations in the Serpina1 gene, particularly the Z variant (Glu342Lys), lead to alpha-1 antitrypsin deficiency (AATD), resulting in emphysema and chronic obstructive pulmonary disease (COPD) due to uncontrolled protease activity. Additionally, misfolded AAT accumulation in hepatocytes may cause cirrhosis or hepatocellular carcinoma [1-3]. The affected tissues primarily include the liver and lungs, with the former being damaged by protein aggregation and the latter by tissue destruction. This highlights AAT's systemic role in protease regulation and disease pathology.
In mice, the Serpina1 gene cluster is located on chromosome 12, spanning a 230 kb genomic region, and encompasses five liver-specific human SERPINA1 homologous genes, which are arranged in the following order: Serpina1b, Serpina1d, Serpina1a, Serpina1c, and Serpina1e. The B6-hSERPINA1 mouse is a humanized model constructed by replacing the mouse Serpina1 gene cluster (from upstream of mouse Serpina1e to downstream of mouse Serpina1b) with the human SERPINA1 gene (from upstream to downstream of human SERPINA1). Homozygous B6-hSERPINA1 mice are viable and fertile and can be used to study the pathogenic mechanisms of emphysema and chronic obstructive pulmonary disease (COPD), cirrhosis, and hepatocellular carcinoma, as well as to develop related therapeutic approaches.
Reference
Stoller, J. K., & Aboussouan, L. S. (2012). Alpha1-antitrypsin deficiency. The Lancet, 365(9478), 2225-2236.
Greene CM, McElvaney NG. Z α-1 antitrypsin deficiency and the endoplasmic reticulum stress response. World J Gastrointest Pharmacol Ther. 2010 Oct 6;1(5):94-101.
Lomas DA, Mahadeva R. Alpha1-antitrypsin polymerization and the serpinopathies: pathobiology and prospects for therapy. J Clin Invest. 2002 Dec;110(11):1585-90.
Strain Strategy
Figure 1. Gene editing strategy of B6-hSERPINA1 Mice. The mouse Serpina1 gene cluster (from upstream of mouse Serpina1e to downstream of mouse Serpina1b) was replaced with the human SERPINA1 gene (from upstream to downstream of human SERPINA1).
Application Area
Pathogenesis research and therapeutic drug evaluation for emphysema and chronic obstructive pulmonary disease (COPD);
Pathogenesis research and therapeutic drug evaluation for liver cirrhosis or hepatocellular carcinoma.
Contact Us
Connect with our experts for your custom animal model needs. Please fill out the form below to start a conversation or request a quote.
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
